MedTrace Logo

VFORM: Prospective, Open Label, Study to Evaluate VOLIFT With Lidocaine Treatment for FORehead Contouring and Marionette Lines

NCT05077488 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 163

Last updated 2022-11-30

No results posted yet for this study

Summary

To collect post-marketing data on Juvéderm® VOLIFT™ with Lidocaine on the following indications:

1. Marionette lines (treatment skin depressions)
2. Forehead contouring (face contouring)

Conditions

  • Marionette Lines Forehead Contouring

Interventions

DEVICE

Juvéderm® VOLIFT™ with Lidocaine

Sterile gel in disposable syringe

Sponsors & Collaborators

  • Eurofins Dermscan Pharmascan

    collaborator INDUSTRY

  • Allergan

    lead INDUSTRY

Principal Investigators

  • ALLERGAN INC. · Allergan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-15
Primary Completion
2022-11-08
Completion
2022-11-08

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05077488 on ClinicalTrials.gov